Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies

dc.date.accessioned2020-04-20T19:47:25Z
dc.date.accessioned2022-10-18T23:09:03Z
dc.date.available2020-04-20T19:47:25Z
dc.date.available2022-10-18T23:09:03Z
dc.date.created2020-04-20T19:47:25Z
dc.date.issued2014
dc.identifierhttp://hdl.handle.net/10533/241699
dc.identifier1140010
dc.identifierWOS:000335195300024
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4473033
dc.description.abstractAcute respiratory infections caused by the respiratory syncytial virus (RSV) are important health burdens that affect infants worldwide. RSV is also an important cause of morbidity and disease in adults, which causes enormous economic losses. At the prese
dc.languageeng
dc.relationhttps://doi.org/10.1002/jmv.23807
dc.relation10.1002/jmv.23807
dc.titleRespiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies
dc.typeArticulo


Este ítem pertenece a la siguiente institución